Press "Enter" to skip to content


Mallinckrodt soars 10% on strong Q3

Pharmaceutical company Mallinckrodt plc (MNK) Tuesday reported third-quarter results that topped analysts’ estimates, sending its shares up 10% during pre-market hours. Earnings rose to $113.8…

Mylan posts better-than-expected Q3 profit

Global pharmaceutical company Mylan N.V. (MYL) reported 100% surge in earnings for the third quarter helped by lower costs and expenses as well as a…